Nutrient’s Role Confirmed in Childhood Blood Cancer – Dietary Limits May Help

Child Cancer Leukemia

A molecular building block of many animal proteins, the amino acid valine, plays a key role in cancerous growth seen in T cell acute lymphoblastic leukemia, a new study shows.

Led by researchers at NYU Langone Health, its Department of Pathology, and the Laura and Isaac Perlmutter Cancer Center, the study showed that genes involved in using up valine in cells were more active in cancerous T cells than in normal T cells.

Blocking these valine-linked genes not only led to decreased valine in leukemia blood T cells, but also stalled these tumor cells from growing in the lab. Only 2 percent of cancerous T cells remained alive.

Further, experiments suggested that changes (mutations) in the DNA code of the gene NOTCH1, the most commonly seen in patients who develop leukemia, encourage cancer growth in part by increasing valine levels.

Published in the journal Nature online on December 22, 2021, the research involved experiments in human leukemia cells grown in the lab and also transplanted into mice that then develop this cancer, which has its origins in white blood cells in the bone marrow.

Further experiments showed that feeding the leukemic mice low-valine diets for three weeks interrupted tumor growth. The diet also reduced circulating blood cancer cells by at least half and in some cases to undetectable levels. By contrast, re-introduction of valine to the diets led to cancer progression.

“Our study confirms that T cell acute lymphoblastic leukemia is absolutely dependent on a supply of valine and that valine deficiency can stall this cancer’s progression,” says study co-lead investigator Palaniraja Thandapani, PhD, a postdoctoral fellow at NYU Grossman School of Medicine and its Perlmutter Cancer Center.

The research team has plans next year to test whether diets low in valine-rich foods, such as meat, fish, and beans, are an effective treatment in people with the cancer. Low-valine diets are readily available, Thandapani says, as they are already being used to treat acid imbalances in the body tied to genetic disorders that affect gut metabolism.

Senior study investigator Iannis Aifantis, PhD, says the trial design would likely combine diet therapy with venetoclax, a drug already approved for use in the United States for most other types of leukemia.

Drug combination is important, he says, because such dietary restrictions are not likely sustainable in the long term. This is due to the known potential for muscle wasting and brain damage from prolonged valine deficiency.

“Our clinical approach would involve using low-valine diets to shrink the number of T cells with acute lymphoblastic leukemia to a level so low that drugs could then effectively stall cancer progression,” says Aifantis, the Hermann M. Biggs Professor and chair of the Department of Pathology at NYU Grossman and Perlmutter.

Aifantis says many basic cell building blocks, including proteins, nucleotides, and fatty acids, are needed for cancer to grow and spread. At least half a dozen other

Amino acids are a set of organic compounds used to build proteins. There are about 500 naturally occurring known amino acids, though only 20 appear in the genetic code. Proteins consist of one or more chains of amino acids called polypeptides. The sequence of the amino acid chain causes the polypeptide to fold into a shape that is biologically active. The amino acid sequences of proteins are encoded in the genes. Nine proteinogenic amino acids are called “essential” for humans because they cannot be produced from other compounds by the human body and so must be taken in as food.

“>amino acids, especially high levels of lysine, have been implicated in cancers, but their precise roles remain unknown. He cautions that dietary strategies alone for treating cancer have been tried for decades with little scientific evidence of any benefit. He says more research is needed, including the team’s planned clinical trial, before any treatment guidelines can be recommended.

The American Cancer Society estimates that more than 1,500 Americans, mostly children, die each year from T cell acute lymphoblastic leukemia. Another 5,000 will be newly diagnosed. This type of cancer accounts for roughly one-quarter of all leukemias.

Reference: “Valine tRNA levels and availability regulate complex I assembly in leukaemia” by Palaniraja Thandapani, Andreas Kloetgen, Matthew T. Witkowski, Christina Glytsou, Anna K. Lee, Eric Wang, Jingjing Wang, Sarah E. LeBoeuf, Kleopatra Avrampou, Thales Papagiannakopoulos, Aristotelis Tsirigos and Iannis Aifantis, 22 December 2021, Nature.
DOI: 10.1038/s41586-021-04244-1

Funding support for the study was provided by National Institutes of Health grants P30CA016087, P01 CA229086 and R01 CA228135; the Leukemia & Lymphoma Society; New York State Department of Health’s NYSTEM program; and the American Association for Cancer Research Incyte Corporation Leukemia Research Fellowship.

Aifantis is a consultant for Foresite Labs, a healthcare investment firm based in San Francisco that has financial interests in the development of leukemia therapies. Study co-investigator Aristotelis Tsirigos, PhD, serves as a scientific advisor to Intelligencia.AI in New York City, a software company that applies machine learning to cancer drug development. The terms of these arrangements are being managed in accordance with the policies of NYU Langone.

Besides Thandapani, Aifantis and Tsirigos, other NYU Langone researchers involved in the study are study co-lead investigators Andreas Kloetgen; Matthew Witkowski; and Christina Glytsou; and study co-investigators Anna Lee; Eric Wang, Jingjing Wang; Sarah LeBoeuf; Kleopatra Avrampou; and Thales Papagiannakopoulos.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Tumeric and 9 Other Botanical Supplements Can Boost Your Health thumbnail

Tumeric and 9 Other Botanical Supplements Can Boost Your Health

Botanical supplements are made from plants, including the root, leaf, flower, stem, and seed. Often used interchangeably with “herbal supplements,” herbs are actually a subset of botanicals. Archaeological evidence points to humans using plants for health-boosting potential as far back as 60,000 years ago — with written records by the Sumerians dating to more than
Read More
How to Deal With Dry Skin in the Winter thumbnail

How to Deal With Dry Skin in the Winter

Photo: Alliance Images (Shutterstock)After finally making it through the hot, sticky summer weather—when it can feel as though you’re permanently sweaty—the crisp, cool fall air feels refreshing. For a few glorious weeks, your skin looks and feels “normal.” Then winter starts, and overnight, your skin dries up.But rather than spending months dealing with itchy, flaky,…
Read More
NSF signs U.S.-India implementation arrangement to streamline the process of funding projects between the two nations thumbnail

NSF signs U.S.-India implementation arrangement to streamline the process of funding projects between the two nations

The U.S. National Science Foundation and India signed an implementation arrangement that streamlines the selection and funding process of research projects from scientists and engineers from the United States and India. India's Ambassador to the U.S., Taranjit Singh Sandhu, joined NSF officials in the signing ceremony held yesterday at the White House as part of the
Read More
Video Friday: Welcome to 2022 thumbnail

Video Friday: Welcome to 2022

Your weekly selection of awesome robot videosVideo Friday is your weekly selection of awesome robotics videos, collected by your friends at IEEE Spectrum robotics. We’ll also be posting a weekly calendar of upcoming robotics events for the next few months; here's what we have so far (send us your events!):ICRA 2022: 23–27 May 2022, PhiladelphiaERF…
Read More
The true cost of climate pollution? 44% of corporate profits. thumbnail

The true cost of climate pollution? 44% of corporate profits.

What if companies had to pay for the problems their carbon emissions cause? Their profits would plunge, according to new estimates, possibly wiping out trillions in financial gains. These results, spelled out in a recent study in the journal Science, are based on analysis of almost 15,000 publicly-traded companies around the world. To calculate how
Read More
Index Of News
Total
0
Share